Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Radiotherapy 8Cisplatin 8Cetuximab 8pembrolizumab 5Fluorouracil 5Drug Therapy 5Surveys and Questionnaires 4Celecoxib 4Radiotherapy, Intensity-Modulated 3Radiation 3Sentinel Lymph Node Biopsy 2Psychiatric Rehabilitation 2Polymerase Chain Reaction 2Physical Therapy Modalities 2Nicotine 2Interviews as Topic 2Injections 2Immunohistochemistry 2High-Energy Shock Waves 2Counseling 2Chemoradiotherapy 2Bupropion 2Aminolevulinic Acid 2trametinib 1traY protein, E coli 1toripalimab 1sodium thiosulfate 1sargramostim 1motexafin gadolinium 1mogamulizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Mouth Neoplasms × TP protocol × Clear all
NCT00933387 2016-05-04

A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma

National Health Research Institutes, Taiwan

Phase 2 Completed
47 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡